89.33K people have invested in this fund
89.33K people have invested
in this fund as of
Total AUM
₹881.78 crores
as of Mar 31, 2025
Age of Fund
3 years 2 months since Feb 14, 2022
Expense Ratio
2.04%
as of Apr 23, 2025
(this includes expense of underlying funds)
Exit Load
Nil
Ideal holding period
10 Years+
Holdings | Weight % |
---|---|
Bluebox Global Technology Fund | 34.9 % |
iShares NASDAQ 100 UCITS ETF | 26.4 % |
KRANESHARES CSI CHINA INTRNT | 17.1 % |
IVZ NASDAQ 100 EW ACC | 12.8 % |
Fidelity Select Medical Technology And Devices Portfolio | 4.1 % |
Bluebox Precision Medicine Fund | 2.1 % |
97.4 % |
Credit rating profile | Weight % |
---|---|
Cash & Equivalent | 100.0 % |
Instrument break-up | Weight % |
---|---|
TREPS | 100.0 % |
Holdings | Weight % |
---|---|
TREPS / Reverse Repo Investments | 2.7 % |
Cash & cash equivalents | -0.2 % |
2.6 % |
Performance highlights over last
for
investment
Cumulative returns on
Annual returns
Current value
Historical Returns (As per SEBI format)as of with investment of₹10,000
This fund | MSCI ACWI Net Total Return ^ | NIFTY 50 TRI # | ||||
---|---|---|---|---|---|---|
CAGR | Current Value | CAGR | Current Value | CAGR | Current Value |
Income distribution Cum Capital Withdrawal (IDCW) Distributed
Record Date | Face Value | IDCW per unit | NAV Before | NAV After |
---|
Funds | Annual returns | Current Value | Absolute Growth |
---|
Date of allotment: Feb 14, 2022.
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement
Different plans shall have a different expense structure. The performance details provided herein are of Regular Plan.
Since inception returns have been calculated from the date of allotment till June 30, 2021
Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments
Rolling returns have been calculated based on returns from regular plan growth option.
Pursuant to payments of Income Distribution cum Capital Withdrawal, the NAV of the IDCW option(s) of Schemes would fall to the extent of payout, and statutory levy, if any.
^ Fund Benchmark # Additional Benchmark
Jay Kothari
The primary investment objective of the scheme is to seek capital appreciation by investing in global mutual fund schemes and ETFs that primarily invest in companies with innovation theme having potential for higher revenue and earnings growth.
The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP Mutual Fund, in order to meet liquidity requirements from time to time.
However, there is no assurance that the investment objective of the Scheme will be realized.
An open ended fund of fund scheme investing in innovation theme.
Level of Risk in the fund
89.33K peoplehave invested in this fund as of